You are here:

Forthcoming Submission: dimethyl fumarate (Skilarence)

Indication: Treatment of moderate to severe plaque psoriasis in adults in need of systemic medicinal therapy.

Drug Details

Drug Name: dimethyl fumarate (Skilarence)
Drug Manufacturer: Almirall Ltd
BNF Category:
Submission type: Full submission
Patient Interest Group
Submission Deadline:
5/02/2018
SMC Meeting Date: 6/03/2018
Advice Due: 9/04/2018

Back